Just In
- 1 hr ago Kamada Ekadashi 2024 Wishes: Greetings, Messages, Texts, Images, Twitter Status And Instagram Captions
- 1 hr ago Deepika Padukone's 6 Refreshing Skincare Tips to Beat the Summer Heat
- 7 hrs ago 7 Questions You Should Ask Your Partner Before Getting Into An Arranged Marriage
- 10 hrs ago Heeramandi: Designers Rimple And Harpreet Craft Inspiring 300 Outfits, Know The Details Here!
Don't Miss
- Finance 5 Bonus, Rs 28/Sh Dividend: IT Giant Infosys Beats Estimates In Q4FY24, But ADR Falls Sharply; Here's Why!
- Sports Who Won Yesterday's IPL Match 33? PBKS vs MI, IPL 2024 on April 17: Mumbai Indians Escape Last-Ditched Fight by Punjab Kings To Win
- Movies Do Aur Do Pyaar OTT Release Date & Platform: When & Where To Watch Vidya Balan’s Film After Theatrical Run?
- News BRS Chief K Chandrasekhar Rao Slams BJP, Says K Kavitha's Arrest Is Vendetta Politics
- Automobiles Aprilia RS 457 Accessories: A Detailed Look At The Prices
- Education Karnataka SSLC Result 2024 Soon, Know How to Check Through Website, SMS and Digilocker
- Technology Nothing Ear, Ear a With ANC, Up to 42.5 Hours of Battery Launched; Check Price and Availability
- Travel Telangana's Waterfall: A Serene Escape Into Nature's Marvels
COVID Antiviral Oral Pill Molnupiravir: Know Price, Dosage, Side Effects And Other Details
The antiviral drug molnupiravir, which received emergency use approval to treat mild to moderate COVID-19 in India recently, was launched on Monday at a price of Rs 1,399 for the full five-day course, making it the cheapest antiviral treatment during the pandemic.
COVID Antiviral Pill Molnupiravir: What You Need To Know
Dr Reddy's Laboratories has launched the antiviral drug molnupiravir at a price of Rs 35 per capsule. The pharma company stated that the affordably-priced molnupiravir capsules 200mg would be launched under the brand name Molflu across India [1].
The chairman of Mankind Pharma, RC Juneja, has said the company is planning to launch Molnupiravir, a COVID-19 antiviral drug, at the cost of 35 rupees per capsule, according to a report that appeared in the Economic Times [2]. A full treatment of Molulife (brand name) will cost Rs 1,399, according to Mankind Pharma chairman. According to Juneja, the product will be available in the next few days.
Molnupiravir is the first oral anti-Covid pill approved by the UK's drug regulator. It was developed by MSD and Ridgeback Biotherapeutics. Molnupiravir has also been approved by the US Food and Drug Administration for the treatment of mild-to-moderate Covid-19 in adults and patients at a high risk of severe illness.
- The drug is approved for limited use in emergencies for treating adults at high risk of COVID-19 progression.
- Thirteen Indian pharmaceutical companies will manufacture the oral pill, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, and Hetero.
What Is Molnupiravir?
Molecularly, molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. The drug is used to treat individuals infected with SARS-CoV-2 who have COVID-19. The recommended dose of Molnupiravir is 800 mg twice a day for 5 days.
Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and it works by introducing copying errors in virus RNA replication [3]. Molnupiravir was originally developed to treat influenza at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was abandoned due to mutagenic concerns (problems posed by some pesticides and their trace impurities) [4].
Who Can Use Molnupiravir?
The purpose of molnupiravir is to treat mild-to-moderate coronavirus disease in adults who have a positive result from a direct SARS-CoV-2 viral test and who are at high risk of developing severe COVID-19 [5].
What Is The Price For Molnupiravir?
Dr Reddy's Molflu will be priced at Rs. 35 per capsule with 10 capsules contained per strip, and the total course of 40 capsules over 5 days costing Rs. 1,400 making it among the most affordable treatment options available to patients.
Mankind Pharma's Molulife (brand name) is also expected to cost Rs 1,400, RC Juneja, chairman of Mankind Pharma.
What Is The Recommended Dosage For Molnupiravir?
Molnupiravir 800 mg should be taken twice daily for five consecutive days. The patient should take 40 capsules containing 200 mg of the drug every day. That is 4 (200 mg) capsules every 12 hours for 5 days in total [6].
What Are The Side Effects of Molnupiravir?
Pregnant women should not use this product. There are no human data on the use of this substance during pregnancy in order to assess the risk of adverse maternal and foetal outcomes. It has been suggested that the drug is likely to cause harm to the foetus based on animal studies [7].
Due to potential adverse reactions in the infant, breastfeeding is not recommended during treatment. There is no information regarding the presence of the drug or its metabolites in human milk. There is no information regarding whether it affects the infant or breast milk production.
In patients under 18 years of age, the use of this medication may adversely affect bone and cartilage development. In rats, bone and cartilage toxicity has been observed after repeated administration [8].
Other mild side effects of molnupiravir include diarrhoea, dizziness and nausea.
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthDo You Pick Your Nose? Stop! It Can Increase COVID Risk
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthVitamin D Deficiency Linked With Increased Risk Of Long COVID
- healthCOVID Surge In India: Do You Need A COVID-19 Booster Shot?
- healthCOVID-19: IMA Cites 3 Reasons Behind Recent Surge In Covid-19 Cases: What Are They?